Estrogen-deficient woman at clinical risk for osteoporosis

Individual with vertebral abnormalities (eg, osteopenia, vertebral fractures, osteoporosis)

Individual receiving long-term (>3 months) glucocorticoid therapy

Primary hyperparathyroidism

Individual monitored to assess response to osteoporosis drug therapy